Opportunity Information: Apply for TI 23 004
Improving Access to Overdose Treatment (Funding Opportunity Number TI 23 004) is a discretionary grant program from the U.S. Department of Health and Human Services, administered by the Substance Abuse and Mental Health Services Administration (SAMHSA), under CFDA 93.243. The core goal is to reduce deaths from opioid overdose by expanding practical, on-the-ground access to naloxone and other FDA-approved overdose reversal medications used for the emergency treatment of known or suspected opioid overdose. The program is designed to strengthen local overdose response capacity by ensuring that more people who are at risk, and the people around them, can obtain and appropriately use these lifesaving medications.
A central feature of the opportunity is its emphasis on community-level collaboration among prescribers. Grant recipients are expected to work directly with other prescribing professionals and partners in their communities to implement trainings that improve how overdose reversal medications are prescribed and made available. These trainings focus on real-world policies, procedures, and models of care, including prescribing and co-prescribing practices that can broaden access. In practice, this means helping clinical and community systems adopt clearer workflows and consistent protocols so that naloxone (and other FDA-approved reversal options) is routinely offered in appropriate settings rather than treated as an exception.
The program targets a defined "population of focus," which applicants identify as either rural or urban. That focus signals that funded activities should be tailored to the specific barriers and service realities of the selected setting, such as long travel distances, limited provider availability, pharmacy access constraints, or high-overdose-burden neighborhoods and service networks. The expectation is that recipients will not only distribute information but also operationalize sustainable approaches for expanding availability through prescribers and related community channels, supported by structured training and agreed-upon care models.
Funding is provided through grants, with an award ceiling of $200,000. SAMHSA anticipated making approximately 7 awards under this opportunity. The notice was created on January 23, 2023, with an original application closing date of March 24, 2023. Eligibility is listed as "Others," with additional eligibility details referenced in the full announcement, meaning prospective applicants would need to confirm their status against the specific eligibility language in the complete funding notice before applying.
Overall, this opportunity is aimed at moving overdose reversal medications closer to the point of need by aligning prescribers, policies, and community practices. The intended outcome is broader, more consistent access to naloxone and other FDA-approved overdose reversal medications, supported by training and coordinated models of care that improve readiness to respond quickly to suspected opioid overdoses in the chosen rural or urban focus area.Apply for TI 23 004
- The Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis in the health sector is offering a public funding opportunity titled "Improving Access to Overdose Treatment" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.243.
- This funding opportunity was created on Jan 23, 2023.
- Applicants must submit their applications by Mar 24, 2023. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- The number of recipients for this funding is limited to 7 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity and who administers it?
The opportunity is called Improving Access to Overdose Treatment and it is listed under Funding Opportunity Number TI 23 004. It is a discretionary grant program from the U.S. Department of Health and Human Services (HHS) and is administered by the Substance Abuse and Mental Health Services Administration (SAMHSA). It is associated with CFDA 93.243.
What is the main goal of the program?
The core goal is to reduce deaths from opioid overdose by expanding practical access to naloxone and other FDA-approved overdose reversal medications that are used for the emergency treatment of known or suspected opioid overdose.
What types of medications does the program focus on?
The program specifically emphasizes naloxone as well as other FDA-approved overdose reversal medications used for emergency treatment of known or suspected opioid overdose.
How does the program plan to improve access to overdose reversal medications?
The program is designed to strengthen local overdose response capacity by ensuring that more people who are at risk, and the people around them, can obtain and appropriately use lifesaving overdose reversal medications. A key approach described is implementing trainings and establishing clearer policies, procedures, and models of care that make prescribing and availability more routine and consistent in real-world settings.
What is the emphasis on prescribers and community collaboration?
A central feature is community-level collaboration among prescribers. Recipients are expected to work directly with other prescribing professionals and partners in their communities to implement trainings that improve how overdose reversal medications are prescribed and made available.
What do the required trainings focus on?
The trainings focus on practical, real-world policies, procedures, and models of care. This includes prescribing and co-prescribing practices intended to broaden access, as well as helping clinical and community systems adopt clearer workflows and consistent protocols.
What does it mean to make naloxone availability more routine?
Based on the description, the intent is for naloxone (and other FDA-approved reversal options) to be routinely offered in appropriate settings rather than treated as an exception, supported by consistent protocols and workflows.
What is the “population of focus” and how is it selected?
Applicants identify their population of focus as either rural or urban. This selection signals that funded activities should be tailored to the barriers and service realities of the chosen setting.
What kinds of barriers or realities are mentioned for rural or urban focus areas?
Examples provided include long travel distances, limited provider availability, pharmacy access constraints, and high-overdose-burden neighborhoods and service networks. The program expects recipients to tailor activities to these types of conditions depending on the selected rural or urban focus.
Is the program focused only on education and information distribution?
No. The description emphasizes that recipients are expected to operationalize sustainable approaches for expanding availability through prescribers and related community channels, supported by structured training and agreed-upon care models, not only distribute information.
What is the funding mechanism for this opportunity?
Funding is provided through grants.
What is the maximum award amount?
The award ceiling is $200,000.
How many awards were expected to be made?
SAMHSA anticipated making approximately 7 awards under this opportunity.
When was the notice created and what was the original application due date?
The notice was created on January 23, 2023, and the original application closing date was March 24, 2023.
Who is eligible to apply?
Eligibility is listed as “Others,” with additional eligibility details referenced in the full announcement. Prospective applicants would need to confirm eligibility by reviewing the specific eligibility language in the complete funding notice.
What are the intended outcomes of the program?
The intended outcome is broader, more consistent access to naloxone and other FDA-approved overdose reversal medications. This is expected to be supported by training and coordinated models of care that improve readiness to respond quickly to suspected opioid overdoses in the chosen rural or urban focus area.
What is the overall strategy described in the opportunity?
The opportunity is aimed at moving overdose reversal medications closer to the point of need by aligning prescribers, policies, and community practices. The strategy centers on strengthening local response capacity through structured trainings, consistent prescribing/co-prescribing practices, and community coordination.
Browse more opportunities from the same category: Health
Next opportunity: DoD Breast Cancer, Era of Hope Scholar Award
Previous opportunity: Addressing Systems Challenges through Engineering Teams
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for TI 23 004
Applicants also applied for:
Applicants who have applied for this opportunity (TI 23 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| State Pilot Program for Treatment for Pregnant and Postpartum Women Apply for TI 23 003 Funding Number: TI 23 003 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $900,000 |
| Sustain and Accelerate a Comprehensive HIV Response in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH 23 0022 Funding Number: CDC RFA GH 23 0022 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening the Quality, Accessibility, and Sustainability of the National Health Laboratory System (NHLS) in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH 23 0023 Funding Number: CDC RFA GH 23 0023 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Multi-Regional Mechanism for Accelerating and Sustaining Epidemic Control in the Republic of Uganda through the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH 23 0027 Funding Number: CDC RFA GH 23 0027 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Hospital-based Quality Improvement Collaborative to Improve Maternity Care Practices Supportive of Breastfeeding Apply for CDC RFA DP 23 0018 Funding Number: CDC RFA DP 23 0018 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $2,000,000 |
| Strengthening Regional, National, and Subnational Institutional Capacities to Sustainably Combat HIV/AIDS and Tuberculosis under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH 23 0044 Funding Number: CDC RFA GH 23 0044 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Promoting, Strengthening and Enhancing Disease Prevention through Collaboration with Targeted Partnerships Apply for CDC RFA IP 23 0001 Funding Number: CDC RFA IP 23 0001 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| USAID Integrated Nutrition Apply for RFI 367 23 00002 Funding Number: RFI 367 23 00002 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Implementing Innovative Activities to Reach Epidemic Control in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH 23 0020 Funding Number: CDC RFA GH 23 0020 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Transitioning and Integrating Laboratory Services for High Quality HIV Diagnosis, Care, Treatment, and Monitoring to the Ministry of Health (MOH) to Sustain Achievement of the 95-95-95 Goals in Zambia under PEPFAR Apply for CDC RFA GH 23 0010 Funding Number: CDC RFA GH 23 0010 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| National Child Traumatic Stress Initiative – Category III, Community Treatment and Services (CTS) Centers Apply for SM 23 010 Funding Number: SM 23 010 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $600,000 |
| Enhancing the Quality and Reach of Comprehensive and Sustainable HIV/AIDS Prevention Services in the Republic of Zambia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH 23 0009 Funding Number: CDC RFA GH 23 0009 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Enhancing Comprehensive Community-Based and Sustainable HIV/AIDS Key Population (KP) Prevention Services and Treatment Support for KP Living with HIV in the Republic of Zambia under PEPFAR Apply for CDC RFA GH 23 0011 Funding Number: CDC RFA GH 23 0011 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| BJA FY 23 Improving Adult and Youth Crisis Stabilization and Community Reentry Program Apply for O BJA 2023 171525 Funding Number: O BJA 2023 171525 Agency: Department of Justice, Bureau of Justice Assistance Category: Health Funding Amount: $7,500,000 |
| Strengthening Local Capacity to Deliver HIV/AIDS Prevention, Care and Treatment Activities for Key Populations in the Republic of Côte d’Ivoire under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH 23 0030 Funding Number: CDC RFA GH 23 0030 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening Local Capacity to Deliver Comprehensive HIV/AIDS Prevention, Care and Treatment Activities in the Republic of Côte d’Ivoire under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH 23 0031 Funding Number: CDC RFA GH 23 0031 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Drug-Free Communities (DFC) Support Program- Competing Continuation (Year 6) Apply for CDC RFA CE20 2004CC23 Funding Number: CDC RFA CE20 2004CC23 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $125,000 |
| Drug-Free Communities (DFC) Support Program- NEW (Year 1) Apply for CDC RFA CE 23 0004 Funding Number: CDC RFA CE 23 0004 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $125,000 |
| Technical Assistance to National Entities and Regional Health Bureaus (RHBs) in the Implementation of HIV Programs across Ethiopia under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH 23 0014 Funding Number: CDC RFA GH 23 0014 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| HIV Care and Treatment Activity Apply for 72069523RFA00001 Funding Number: 72069523RFA00001 Agency: Agency for International Development, Burundi USAID-Bujumbura Category: Health Funding Amount: $47,900,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "TI 23 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.